Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations

Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations

US Patent 11446302 · Granted Sep 20, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Molecular subtyping of small cell lung cancer to predict therapeutic responses2023
Heterocyclic inhibitors of tyrosine kinase2022
Heterocyclic inhibitors of tyrosine kinase2022
Heterocyclic inhibitors of tyrosine kinase2022
Binned micro-vessel density methods and apparatus2013